SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical : ARRIS - Another partner -- Ignore unavailable to you. Want to Upgrade?

To: Pseudo Biologist who wrote (236)11/20/1997 6:28:00 PM
From: chirodoc  Read Replies (1) | Respond to of 353
 
thanks for info on incy and arris/sqna

...................another poster on xoma said this about walker.......

It's interesting that you would bring up Arris in a discussion of questionable biotech managements. Worth magazine did an article a couple months ago on the six or so managers (in any industry) that best maximize shareholder value. Walker of Arris was one of them. Nice write-up.

..........i think that analysis of this type of deal will be important--hooking up your caboose to a big pharma may not be the only model of success for the bios--we'll all be watching.

.........thanks again



To: Pseudo Biologist who wrote (236)11/21/1997 8:06:00 PM
From: Howard Henick  Read Replies (2) | Respond to of 353
 
I was intrigued by the stock drop post merger but am a little scared by Walkers commernt in the press release that they hope to be profitable by 2002! 5 years is a long time away. Comments?


HomeMailHotSubjectMarksPeopleMarksKeepersSettings
Terms Of UseContact UsCopyright/IP PolicyPrivacy PolicyAbout UsFAQAdvertise on SI
© 2026 Knight Sac Media.  Data provided by Twelve Data, Alpha Vantage, and CityFALCON News